Rezolute (RZLT) Receivables - Other (2013 - 2023)

Rezolute recorded quarterly Expense - Property Taxes and Insurance of $38164.0 in Q3 2014, up 19.26% quarter-over-quarter from $32000.0 in Q2 2014, and down 14.84% year-over-year from $44813.0 in Q3 2013.

Rezolute's Expense - Property Taxes and Insurance history runs 3 years deep, the most recent figure standing at $38164.0 for Q3 2014.

  • In Q3 2014, Expense - Property Taxes and Insurance fell 14.84% year-over-year to $38164.0; the TTM figure through Sep 2014 stood at $148073.0 (up 4.39% YoY), while the FY2014 annual figure was $154722.0, up 52.77% from the prior year.
  • Receivables - Other came in at $400000.0 for Q3 2023 at Rezolute, up from $300000.0 in the prior quarter.
  • In the past five years, Expense - Property Taxes and Insurance ranged from a high of $48514.0 in Q2 2013 to a low of $3443.0 in Q1 2012.
  • A 3-year average of $27753.5 and a median of $33645.0 in 2014 frame the typical range for Expense - Property Taxes and Insurance.
  • Across the five-year window, Expense - Property Taxes and Insurance soared 1182.2% in 2013 and slumped 34.04% in 2014, its largest moves.
  • Rezolute's Receivables - Other stood at $247000.0 in 2019, then jumped by 61.94% to $400000.0 in 2023.
  • According to Business Quant data, Receivables - Other over the past three periods registered $400000.0, $300000.0, and $300000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rezolute 374.41 Mn 374.41 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 400,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 300,000.00
Jun 30, 2023 300,000.00
Mar 31, 2023 300,000.00
Mar 31, 2023 300,000.00
Sep 30, 2019 247,000.00
Sep 30, 2019 247,000.00
Mar 31, 2018 500,000.00
Mar 31, 2018 500,000.00
Dec 31, 2013 165,023.00
Dec 31, 2013 165,023.00
Sep 30, 2013 60,919.00
Sep 30, 2013 60,919.00
Jun 30, 2013 183,346.00
Jun 30, 2013 183,346.00
Mar 31, 2013 128,546.00
Mar 31, 2013 128,546.00